New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
作者信息
van der Wall E E
机构信息
Interuniversity Cardiology Institute of the Netherlands (ICIN) - Netherlands Heart Institute (NHI), PO Box 19258, 3501, DG, Utrecht, the Netherlands,
出版信息
Neth Heart J. 2015 Jan;23(1):1-3. doi: 10.1007/s12471-014-0636-7.
Abstract
摘要
相似文献
1
New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
Neth Heart J. 2015 Jan;23(1):1-3. doi: 10.1007/s12471-014-0636-7.
2
[The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].
Herz. 2014 Dec;39(8):919-30. doi: 10.1007/s00059-014-4177-z.
3
[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].
Kardiol Pol. 2014;72(11):1054-126. doi: 10.5603/KP.2014.0212.
4
The 2014 ESC Guidelines on the Diagnosis and Management of Hypertrophic Cardiomyopathy have been published.
Eur Heart J. 2014 Nov 1;35(41):2849-50. doi: 10.1093/eurheartj/ehu375.
5
Comments on the 2014 ESC Guidelines on the diagnosis and management of hypertrophic cardiomyopathy. A critical view from the perspective of Spanish cardiology.
Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):4-9. doi: 10.1016/j.rec.2014.10.011.
6
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
7
Aortic valve closure during early or middle systole.
Herz. 1980 Oct;5(5):285-90.
8
Hypertrophic cardiomyopathy.
Heart Lung Circ. 2004;13 Suppl 3:S48-55. doi: 10.1016/j.hlc.2004.09.021.
9
Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014).
Cardiovasc Ultrasound. 2017 Sep 13;15(1):24. doi: 10.1186/s12947-017-0115-6.
10
Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy.
Int J Cardiol. 2018 Mar 1;254:175-181. doi: 10.1016/j.ijcard.2017.10.033. Epub 2018 Jan 28.
引用本文的文献
1
Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
ESC Heart Fail. 2023 Jun;10(3):1570-1579. doi: 10.1002/ehf2.14272. Epub 2023 Jan 13.
2
Large pericardial mesothelial cyst coexisting with hypertrophic obstructive cardiomyopathy.
ARYA Atheroscler. 2020 Mar;16(2):102-104. doi: 10.22122/arya.v16i2.2014.
3
Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.
Neth Heart J. 2017 Mar;25(3):186-199. doi: 10.1007/s12471-016-0943-2.
4
New guidelines on primary PCI for patients with STEMI: changing insights.
Neth Heart J. 2016 Feb;24(2):93-5. doi: 10.1007/s12471-015-0780-8.
5
ESC Congress 2015, London: hot lines truly hot?
Neth Heart J. 2015 Nov;23(11):505-7. doi: 10.1007/s12471-015-0750-1.
本文引用的文献
1
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
2
Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
Expert Rev Cardiovasc Ther. 2014 Sep;12(9):1041-4. doi: 10.1586/14779072.2014.942287. Epub 2014 Jul 21.
3
ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study).
Neth Heart J. 2013 Dec;21(12):567-71. doi: 10.1007/s12471-013-0478-8.
4
Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy.
Neth Heart J. 2013 Nov;21(11):504-9. doi: 10.1007/s12471-013-0453-4.
5
Electrocardiogram in apical hypertrophic cardiomyopathy with a speculation as to the mechanism of its features.
Neth Heart J. 2013 Jun;21(6):268-71. doi: 10.1007/s12471-013-0400-4.
6
Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation.
Neth Heart J. 2013 May;21(5):245-8. doi: 10.1007/s12471-013-0393-z.
7
Pregnancy in women with hypertrophic cardiomyopathy.
Neth Heart J. 2013 Jan;21(1):14-8. doi: 10.1007/s12471-012-0358-7.
8
Dizzy spells in a patient with hypertrophic obstructive cardiomyopathy and a pacemaker.
Neth Heart J. 2011 Jan;19(1):50-1. doi: 10.1007/s12471-010-0051-7.
9
Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.
Eur Heart J. 2011 May;32(9):1055-8. doi: 10.1093/eurheartj/ehr006. Epub 2011 Feb 14.
10
Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.
Circ Heart Fail. 2010 May;3(3):362-9. doi: 10.1161/CIRCHEARTFAILURE.109.862359. Epub 2010 Mar 23.
Zotero 插件